San Diego, CA, United States of America

Lei Jia

This inventor holds 15 USPTO granted patents and 9 published patent applications, plus 4 CIPO patents and 6 EPO patents. Top assignees: Cyclerion Therapeutics, Inc., Agouron Pharmaceuticals, Inc., Amgen Inc.. Active years: 2003-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lei Jia. Retrieved from https://idiyas.com/inventor/lei-jia-rlj13z50

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15 

% Patents Active = 80.0

 

 

Average Co-Inventor Count = 12.5

ph-index = 5

Forward Citations = 179(Granted Patents)


Location History:

  • San Diego, CA (US) (2003 - 2021)
  • Belmont, MA (US) (2021)

Company Filing History:


Years Active: 2003-2025

Loading Chart...
Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents

Title: Lei Jia: Innovator in sGC Stimulators

Introduction: Lei Jia is a notable inventor based in San Diego, CA, known for his significant contributions in the field of pharmaceutical formulations, particularly in the development of stimulators for soluble guanylate cyclase (sGC). With a total of 11 patents to his name, his work aims to address various disorders through innovative compounds.

Latest Patents: Among Lei Jia's recent innovations are his patents relating to sGC stimulators. His patents define compounds of Formulae I that serve as stimulators of sGC, specifically targeting heme-dependent, NO-independent functions. These compounds are poised to be beneficial in treating, preventing, or managing a range of disorders. The current disclosures also extend to pharmaceutical formulations that combine these stimulators with other agents, promoting increased concentrations of nitric oxide (NO) and cyclic Guanosine Monophosphate (cGMP), which are vital for treating several diseases.

Career Highlights: Over the course of his career, Lei Jia has worked with notable organizations such as Cyclerion Therapeutics, Inc. and Agouron Pharmaceuticals, Inc. His work within these companies has significantly advanced research in therapeutic applications, particularly focusing on sGC stimulators.

Collaborations: Lei Jia has collaborated with exceptional colleagues in his field, including Mitchell David Nambu and Jingrong Jean Cui, showcasing his commitment to teamwork and shared innovation. The collaborative efforts contribute to the enhancement of his groundbreaking work in the pharmaceutical industry.

Conclusion: Lei Jia stands out as a visionary inventor whose innovative solutions in the area of sGC stimulators are paving the way for advancements in treatment methodologies. His 11 patents reflect a dedicated pursuit of scientific excellence and a commitment to improving health outcomes through innovative therapeutic compounds.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…